Zhongyi Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhongyi Sun has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Fanchun Zeng
Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Medical School, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, Shenzhen University, Shenzhen, China
2 shared publications Fengwen Fu
Department of Urinary Surgery, Daping Hospital, Third Military Medical University, Chongqing, China
2 shared publicationsMinggan Guo
2 shared publicationsQuanfu Cao
Department of Urinary Surgery, Daping Hospital, Third Military Medical University, Chongqing, China
2 shared publicationsYuan Chen
2 shared publications- Bin Wang
Department of Urology, Shenzhen University General Hospital, Shenzhen, China
1 shared publication
Latest Publications
- Open Access
- 22 July 2026
- Published by AccScience Publishing in International Journal of Bioprinting
- Vol. 12 (5) , 026240248
Clinical translation of 3D-bioprinted orthopedic grafts: Design specifications, evaluation domains, and regulatory considerations for bone, cartilage, and osteochondral repair
Three-dimensional (3D) bioprinting has advanced rapidly, but clinical translation of orthopedic grafts remains constrained by a mismatch between printable constructs and indication-specific failure modes. Bone, cartilage, and osteochondral defects impose distinct requirements: vascularized remodeling and load sharing for bone, phenotypic stability and low-friction durability for cartilage, and mechanically integrated compartmental organization for osteochondral repair. This narrative review synthesizes recent evidence on 3D-bioprinted orthopedic grafts with a translational focus on design specifications, validation endpoints, manufacturing control, and regulatory readiness. Rather than treating bioinks, printing platforms, and cell sources as isolated technologies, the review organizes them according to clinical function: structural support, biological instruction, process control, maturation, immune compatibility, and product qualification. Current evidence indicates that many constructs remain validated mainly by early biological markers, representative imaging, or short-term animal outcomes, whereas clinically relevant tests of fatigue, wear, degradation-coupled mechanics, host–graft integration, vascular perfusion, immune response, sterility, dimensional tolerances, and release criteria are less consistently reported. Near-term translation appears most plausible for acellular or minimally cellular reinforced constructs, patient-specific but quality-testable bone scaffolds, and selected intraoperative applications with clear surgical utility. More complex living grafts that combine vascular, immune-instructive, and multi-tissue functions will require stronger preclinical models, standardized reporting, and product-specific regulatory strategies. Translation in orthopedic bioprinting should begin with the clinical failure mode and proceed toward measurable release specifications, not with printability alone.
- 22 July 2026
- Published by AccScience Publishing in International Journal of Bioprinting
- Vol. 12 (5) , 026240248
Open AccessClinical translation of 3D-bioprinted orthopedic grafts: Design specifications, evaluation domains, and regulatory considerations for bone, cartilage, and osteochondral repair
Three-dimensional (3D) bioprinting has advanced rapidly, but clinical translation of orthopedic grafts remains constrained by a mismatch between printable constructs and indication-specific failure modes. Bone, cartilage, and osteochondral defects impose distinct requirements: vascularized remodeling and load sharing for bone, phenotypic stability and low-friction durability for cartilage, and mechanically integrated compartmental organization for osteochondral repair. This narrative review synthesizes recent evidence on 3D-bioprinted orthopedic grafts with a translational focus on design specifications, validation endpoints, manufacturing control, and regulatory readiness. Rather than treating bioinks, printing platforms, and cell sources as isolated technologies, the review organizes them according to clinical function: structural support, biological instruction, process control, maturation, immune compatibility, and product qualification. Current evidence indicates that many constructs remain validated mainly by early biological markers, representative imaging, or short-term animal outcomes, whereas clinically relevant tests of fatigue, wear, degradation-coupled mechanics, host–graft integration, vascular perfusion, immune response, sterility, dimensional tolerances, and release criteria are less consistently reported. Near-term translation appears most plausible for acellular or minimally cellular reinforced constructs, patient-specific but quality-testable bone scaffolds, and selected intraoperative applications with clear surgical utility. More complex living grafts that combine vascular, immune-instructive, and multi-tissue functions will require stronger preclinical models, standardized reporting, and product-specific regulatory strategies. Translation in orthopedic bioprinting should begin with the clinical failure mode and proceed toward measurable release specifications, not with printability alone.
- Open Access
- 6 February 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Biological welding enables rapid and efficient bladder cystotomy closure and reveals the underlying repair mechanism
Bladder rupture repair surgery is limited by its long duration, significant blood loss, and complex procedures. Biological welding technology, which integrates multiple functions such as cutting, hemostasis, and tissue fusion, has shown potential in the field of soft tissue repair surgery but has not yet been widely explored in clinical applications for bladder rupture repair. This study used 32 adult male Beagle dogs to establish a bladder rupture model, randomly assigned to the biological welding group or the traditional suturing group. Outcomes assessed included surgical time, blood loss, postoperative inflammation, and hematuria. Histopathological analysis and RNA sequencing analysis were performed at multiple postoperative time points to evaluate the tissue recovery process and repair mechanisms. The results demonstrated that biological welding significantly reduced surgical time (21.80 ± 4.79 min vs. 75.15 ± 13.26 min, p < 0.001) and intraoperative blood loss (6.37 ± 0.89 g vs. 30.36 ± 6.59 g, p < 0.001) compared to traditional suturing. Postoperative complications, such as hematuria and inflammatory response, were notably lower in the biological welding group. Histopathological analysis revealed enhanced cell migration and tissue fusion in the biological welding group, leading to accelerated bladder healing and reduced adhesions. Transcriptomic sequencing indicated that biological welding activated a limited number of immune-related genes and signaling pathways in the early postoperative period, facilitating rapid repair and a shorter duration of abnormal gene expression. Our research indicates that biological welding technology demonstrates significant advantages in bladder rupture repair surgery, including enhanced surgical efficiency, reduced incidence of postoperative complications, and accelerated tissue healing process, with broad prospects for clinical application.
- 6 February 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessBiological welding enables rapid and efficient bladder cystotomy closure and reveals the underlying repair mechanism
Bladder rupture repair surgery is limited by its long duration, significant blood loss, and complex procedures. Biological welding technology, which integrates multiple functions such as cutting, hemostasis, and tissue fusion, has shown potential in the field of soft tissue repair surgery but has not yet been widely explored in clinical applications for bladder rupture repair. This study used 32 adult male Beagle dogs to establish a bladder rupture model, randomly assigned to the biological welding group or the traditional suturing group. Outcomes assessed included surgical time, blood loss, postoperative inflammation, and hematuria. Histopathological analysis and RNA sequencing analysis were performed at multiple postoperative time points to evaluate the tissue recovery process and repair mechanisms. The results demonstrated that biological welding significantly reduced surgical time (21.80 ± 4.79 min vs. 75.15 ± 13.26 min, p < 0.001) and intraoperative blood loss (6.37 ± 0.89 g vs. 30.36 ± 6.59 g, p < 0.001) compared to traditional suturing. Postoperative complications, such as hematuria and inflammatory response, were notably lower in the biological welding group. Histopathological analysis revealed enhanced cell migration and tissue fusion in the biological welding group, leading to accelerated bladder healing and reduced adhesions. Transcriptomic sequencing indicated that biological welding activated a limited number of immune-related genes and signaling pathways in the early postoperative period, facilitating rapid repair and a shorter duration of abnormal gene expression. Our research indicates that biological welding technology demonstrates significant advantages in bladder rupture repair surgery, including enhanced surgical efficiency, reduced incidence of postoperative complications, and accelerated tissue healing process, with broad prospects for clinical application.
- 11 December 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-8
Biological welding: a rapid and bloodless approach to circumcision
Background Circumcision is essential for male health, yet traditional methods are plagued by issues such as lengthy operative times, bleeding, and slow recovery. This study explores the application of biological welding technology in circumcision, assessing its potential as a safe and efficient novel surgical approach. Methods In this study, 24 male adult dogs were randomly divided into two groups. The biological welding group underwent circumcision using biological welding technology, while the control group received traditional cut-and-suture circumcision. Clinical indicators such as surgical time, blood loss, pathological changes, and recovery time were observed and compared. Results The biological welding group had a significantly shorter surgical time compared to the control group (2.33 ± 0.55 min vs. 27.06 ± 5.77 min, p < 0.001). The control group had an average blood loss of 22.35 ± 5.17 ml, whereas the biological welding group experienced zero blood loss (p < 0.001). Recovery time was also significantly shorter in the biological welding group (12.33 ± 3.50 d vs. 16.50 ± 2.57 d, p = 0.004), with a lower incidence of postoperative complications. Pathological analysis indicated that the thermal injury range in the biological welding group was controlled within 2 mm. Conclusion Biological welding technology demonstrated advantages in circumcision, including short surgical time, no bleeding, minimal thermal damage, and rapid recovery, proving to be a safe and effective novel circumcision technique with potential clinical application value.
- 11 December 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-8
Biological welding: a rapid and bloodless approach to circumcision
Background Circumcision is essential for male health, yet traditional methods are plagued by issues such as lengthy operative times, bleeding, and slow recovery. This study explores the application of biological welding technology in circumcision, assessing its potential as a safe and efficient novel surgical approach. Methods In this study, 24 male adult dogs were randomly divided into two groups. The biological welding group underwent circumcision using biological welding technology, while the control group received traditional cut-and-suture circumcision. Clinical indicators such as surgical time, blood loss, pathological changes, and recovery time were observed and compared. Results The biological welding group had a significantly shorter surgical time compared to the control group (2.33 ± 0.55 min vs. 27.06 ± 5.77 min, p < 0.001). The control group had an average blood loss of 22.35 ± 5.17 ml, whereas the biological welding group experienced zero blood loss (p < 0.001). Recovery time was also significantly shorter in the biological welding group (12.33 ± 3.50 d vs. 16.50 ± 2.57 d, p = 0.004), with a lower incidence of postoperative complications. Pathological analysis indicated that the thermal injury range in the biological welding group was controlled within 2 mm. Conclusion Biological welding technology demonstrated advantages in circumcision, including short surgical time, no bleeding, minimal thermal damage, and rapid recovery, proving to be a safe and effective novel circumcision technique with potential clinical application value.